Enhanced External Counterpulsation (EECP) is an FDA-approved, non-invasive therapy designed for select heart patients who ...
In the Prospective Evaluation of EECP in Congestive Heart Failure (PEECH) trial, EECP improved exercise duration, symptom status, and QOL in patients with mild-to-moderate heart failure who were ...